Abstract
The steroid hormone 1alpha,25(OH)(2)-Vitamin D(3) [1alpha,25(OH)(2)D(3)] exerts a wide variety of biological actions through one or more receptors/binding proteins. The nuclear Vitamin D receptor (VDR) when bound to its natural ligand, 1alpha,25(OH)(2)D(3), can stimulate transcription of a wide variety of genes. The synthesis of 1alpha,25(OH)(2)D(3) analogs allows the study of structure-function relationships between ligand and the VDR. 1alpha,25(OH)(2)D(3) is a conformationally flexible molecule; specifically the side-chain of the hormone can display a large variety of shapes for its receptor. Here, we describe and analyze the properties of 10 1alpha,25(OH)(2)D(3) analogs modified at the side-chain of which five lack carbon-19 (19-nor) but have a novel 20-cyclopropyl functionality. Analog NG [20,21-methylene-23-yne-26,27-F(6)-19-nor-1alpha,25(OH)(2)D(3)] possesses a respectable binding affinity for the VDR and exhibits a high transcriptional activity (EC(50) approximately 10pM), while retaining low induction of hypercalcemia in vivo in the mouse, making it a primary candidate for further analyses of its anti-proliferative and/or cell differentiating properties.
References
Jan 15, 1979·Analytical Biochemistry·W R Wecksler, A W Norman
Dec 1, 1992·Molecular Endocrinology·J C ReeseB S Katzenellenbogen
Feb 6, 1992·The New England Journal of Medicine·M W TilyardS Dovey
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J Y ZhouH P Koeffler
Apr 1, 1987·Endocrinology·C Cade, A W Norman
Nov 2, 1972·The New England Journal of Medicine·A S BrickmanA W Norman
Aug 15, 1980·Science·A W NormanG M Grodsky
Aug 25, 1995·Biochemical Pharmacology·R BouillonH van Baelen
May 5, 1995·The Journal of Biological Chemistry·S PelegA W Norman
Aug 1, 1994·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·J E BishopA W Norman
Oct 15, 1993·The Biochemical Journal·A HondaS Ishizuka
Oct 1, 1993·Molecular Endocrinology·J M BeekmanB W O'Malley
Jan 15, 1997·The Journal of Clinical Investigation·E ElstnerH P Koeffler
Feb 7, 1997·The Journal of Biological Chemistry·Y Y LiuS Peleg
Mar 1, 1997·Molecular Endocrinology·X Y ZhaoD Feldman
Apr 1, 1997·Molecular and Cellular Biology·B D LemonL P Freedman
Jan 19, 2000·The Prostate·W B Grant
Jun 1, 2000·Transplantation·E van EttenC Mathieu
Jul 14, 2000·Journal of Medicinal Chemistry·A W NormanS Peleg
Feb 17, 2001·Steroids·Y Y LiuS Ali Gradezi
Feb 17, 2001·Steroids·C CarlbergA Toell
Nov 14, 2001·Reviews in Endocrine & Metabolic Disorders·A W Norman, F R Silva
Apr 3, 2002·Trends in Molecular Medicine·Chantal Mathieu, Luciano Adorini
Apr 19, 2002·Steroids·Anthony W NormanWilliam H Okamura
May 3, 2002·Clinical and Experimental Immunology·C GysemansC Mathieu
Jun 1, 2002·Leukemia·Y Hatta, H P Koeffler
Aug 22, 2002·International Immunopharmacology·Luciano Adorini
Sep 17, 2002·Urology·Candace S JohnsonDonald L Trump
Oct 26, 2002·Endocrinology·Vijaya VegesnaH Phillip Koeffler
Dec 24, 2002·Clinical Pharmacology and Therapeutics·Josephia R MuindiDonald L Trump
Apr 12, 2003·Bone·E Van EttenC Mathieu
Aug 6, 2003·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·Anthony W NormanWilliam H Okamura
Jan 7, 2004·Nature Reviews. Drug Discovery·Anthony W NormanDerek P G Norman
Citations
Feb 17, 2001·Steroids·S C MohrR Ray
Mar 21, 2007·The Journal of Steroid Biochemistry and Molecular Biology·Mathew T MizwickiAnthony W Norman
Aug 6, 2005·The Journal of Steroid Biochemistry and Molecular Biology·Igor N Sergeev
Jul 7, 2011·International Journal of Cancer. Journal International Du Cancer·Ryoko OkamotoH Phillip Koeffler
Jun 22, 2013·ChemMedChem·Can-Fei ZhangZhao-Peng Liu